Floatz logo

GELDANAMYCIN, 17-DEMETHOXY-17-(2-PROPENYLAMINO)-

Adult Acute Monocytic Leukemia (M5b)

National Cancer Institute (NCI)Small moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Adult Acute Monocytic Leukemia (M5b) cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Stanford University
Phase 3BBB
Cytosin-Arabinosid
Northwestern University
Phase 3BBB
Idarubicine
Bruno C. Medeiros
Phase 2BBB
Daunorubicin
National Cancer Institute (NCI)
Phase 3BBB
Mitoxantrone
Stanford University
Phase 2BBB

View all 50 →

Same molecule, other indications

GELDANAMYCIN, 17-DEMETHOXY-17-(2-PROPENYLAMINO)- is also rated in:

prostate cancerDormant
B
Indicative ·
59 / 100
View asset →
Hodgkins lymphomaDormant
B
Indicative ·
59 / 100
View asset →
mantle cell lymphomaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →